COMPANY PROFILE

4C medical

Explore full profile

A medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR)

Maple Grove, United StatesFounded 2015Health Tech & Medtech

Valuation $1–2.5B Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About 4C medical

4C Medical Technologies specializes in developing next-generation minimally invasive technologies for treating structural heart diseases, particularly focusing on mitral regurgitation. Their flagship product, AltaValve, is a transcatheter mitral valve replacement (TMVR) system designed to expand the treatable patient population, streamline procedures, and preserve critical cardiac structures. The company operates in the medical device market, serving healthcare providers and patients suffering from heart conditions. Their business model revolves around the research, development, and commercialization of advanced cardiovascular devices. Revenue is generated through the sale of these devices and potentially through partnerships and licensing agreements.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Maple Grove, United States
Employees: 60
Open positions: None listed
Dealroom signal: 55.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Rumoured $1B, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES DOther financing	Mar 2025	$175M	$700M	Boston Scientific	↗
SERIES COther financing	Mar 2022	$35M	$142M	MicroPort CardioFlow	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

4C medical website traffic

Latest recorded traffic for 4C medical is 1.9K monthly website visits, down 24% over the last three months. 4C medical's team grew 13.2% over the past year.

Latest monthly visits1.9K 3-month web change-24% 1-year team growth+13.2%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ICImperative CareImperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke	Campbell, United States	Operational	421	$598M	$1.3B
RTRuixin Intelligent Medical TechnologyAI-powered cardiovascular diagnosis and surgical robotics.	Shenzhen, China	Operational
ESEndoluminal SolutionsPolymer-based platform improving endovascular prostheses performance	Osaka, Japan	Operational
BTBingjing Intelligent Medical TechnologyHigh-definition intracardiac echocardiography for cardiac interventions	China	Operational
POPolyemboVessel embolization device for peripheral vascular procedures	Longmont, United States	Operational
VVVersa VascularMinimally invasive implant for tricuspid valve regurgitation	United States	Operational
AMArcho MedicalEndovascular devices for complex aortic aneurysm treatment	Biguaçu, Brazil	Operational
STShenzhen Saihe Medical TechnologyHealth Tech & Medtech	Ningbo, China	Operational